CelLBxHealth plc Stock OTC Markets
Stocks
ANPCF
GB0034330679
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
09:41:45 2026-04-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.0103 USD | -17.60% |
|
-48.24% | -38.69% |
| Market Cap | 15.06M 20.4M 17.62M 16.56M 28.31M 1.95B 28.78M 194M 75.85M 977M 76.59M 74.93M 3.25B | P/E 2026 * |
-0.57x | P/E 2027 * | -14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 13.46M 18.23M 15.75M 14.8M 25.3M 1.74B 25.72M 173M 67.79M 873M 68.45M 66.97M 2.9B | EV / Sales 2026 * |
0.62x | EV / Sales 2027 * | 0.44x |
| Free-Float |
95.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CelLBxHealth plc
| 25-10-16 | Angle names Peter Collins as interim CEO | AN |
| 25-05-28 | RBC cuts National Grid; Citigroup cuts South32 | AN |
| 25-01-23 | HSBC raises FirstGroup, Goldman cuts Ithaca | AN |
| 23-09-14 | JPMorgan ups Rio Tinto; Redburn likes Carnival | AN |
| 22-01-24 | Berenberg Initiates Angle With Buy Rating, Sets PT | MT |
| 1 day | -17.60% | ||
| 1 week | -48.24% | ||
| Current month | -48.24% | ||
| 1 month | -48.24% | ||
| 6 months | -38.69% | ||
| Current year | -38.69% |
| Current year | 0.01 |  | 0.02 |
| 1 year | 0.01 | | 0.05 |
| 3 years | 0.01 | | 0.35 |
| 5 years | 0.01 | | 1.67 |
| 10 years | 0.01 | | 1.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sinéad Armstrong
DFI | Director of Finance/CFO | - | 1998-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2024-12-31 | |
Karen Miller
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Jan Groen
CHM | Chairman | 67 | 2023-05-21 |
Klaas de Boer
BRD | Director/Board Member | 61 | 2026-01-11 |
| Director/Board Member | 61 | 2026-01-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -17.60% | -48.24% | - | - | 20.4M | |
| +1.02% | +2.28% | +20.16% | -35.79% | 17.1B | |
| -2.98% | +0.45% | -10.29% | +95.57% | 1.76B | |
| -0.44% | -2.23% | -26.22% | +25.14% | 985M | |
| -5.24% | +16.40% | -44.85% | -80.86% | 981M | |
| -0.05% | +48.99% | +70.10% | -11.23% | 779M | |
| +0.95% | +2.45% | -36.26% | -49.55% | 696M | |
| +3.92% | +17.79% | -35.32% | -39.77% | 646M | |
| +5.89% | +6.05% | -40.58% | -36.99% | 443M | |
| -0.99% | +12.73% | +50.98% | +41.78% | 414M | |
| Average | -1.55% | +10.13% | -5.81% | -10.19% | 2.65B | |
| Weighted average by Cap. | +0.49% | +4.21% | +11.20% | -23.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.65M 29.33M 25.33M 23.81M 40.7M 2.8B 41.37M 279M 109M 1.4B 110M 108M 4.67B | 37.75M 51.14M 44.17M 41.51M 70.97M 4.89B 72.14M 486M 190M 2.45B 192M 188M 8.14B |
| Net income | -8.55M -11.58M -10M -9.4M -16.07M -1.11B -16.34M -110M -43.07M -555M -43.49M -42.55M -1.84B | -1.85M -2.51M -2.16M -2.03M -3.48M -240M -3.54M -23.83M -9.32M -120M -9.41M -9.21M -399M |
| Net Debt | -1.6M -2.17M -1.87M -1.76M -3.01M -207M -3.06M -20.61M -8.06M -104M -8.14M -7.96M -345M | 1.4M 1.9M 1.64M 1.54M 2.63M 181M 2.68M 18.04M 7.05M 90.82M 7.12M 6.97M 302M |
Employees
114
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0132GBP
Average target price
0.0400GBP
Spread / Average Target
+201.89%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CLBX Stock
- ANPCF Stock
Select your edition
All financial news and data tailored to specific country editions
